This Week in Healthcare — Washington (#31, 2026)

ALS therapies bill advances; mammography coverage proposal introduced; device reprocessing study bill filed; EMS memorial extension bill action; diabetes prevention reauthorization bill referred.

This Week in Healthcare — Washington (#31, 2026)

August 09, 2026 to August 15, 2026

This is Queen Street Analytics' weekly digest of regulatory developments, legislative discussions and other government-related news concerning healthcare providers, doctors, physicians, clinicians, pharmacies and pharmacists, dental care providers, oral care providers, naturopaths, and old-age care providers. Once a week, we break down the most important updates in this space in under five minutes.

Want to see GR activities in areas of the economy related to the Healthcare channel? Don't miss this week's updates in Social Issues. Also consider subscribing to our Healthcare - Ottawa edition covering critical GR news north of the border.

📋 In This Week's Newsletter

• 📜 Legislative Updates
• 📚 What We're Reading This Week


Legislative Updates

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Bill 4472 seeks to reauthorize provisions supporting expedited access to ALS therapies. The measure was held at the desk for further consideration, indicating pending action before formal referral.

Sources: www.congress.gov

To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to provide for no-cost coverage for annual screening mammography beginning at 30 years of age.

Bill 10100 was introduced to mandate no-cost annual mammography screenings for individuals starting at age 30. The bill is referred to the Committee on Energy and Commerce, and the Committee on Ways and Means, signifying multi-committee review for provisions within respective jurisdictions.

Sources: www.congress.gov

To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to conduct a study to assess the potential for expanding the safe and effective use of reprocessed single-use devices, and for other purposes.

Bill 10088 directs HHS and the FDA Commissioner to initiate a study evaluating expanded use of reprocessed single-use medical devices. The measure was referred to the House Committee on Energy and Commerce for further consideration.

Sources: www.congress.gov

National Plan for Epilepsy Act

Senate Bill 494 proposes the establishment of a national plan to address epilepsy care and research. The bill was held at the desk in the Senate, awaiting next procedural steps.

Sources: www.congress.gov

National Emergency Medical Services Memorial Extension Act

House Bill 2196 extends provisions for the National Emergency Medical Services Memorial. The latest procedural update reflects the Senate's action and communication to the House.

Sources: www.congress.gov

DeOndra Dixon INCLUDE Project Act of 2026

Senate Bill 1838, centering on the INCLUDE Project, targets research and support for individuals with Down syndrome. The bill was held at the desk following Senate action.

Sources: www.congress.gov

Kay Hagan Tick Reauthorization Act

Bill 2398 would reauthorize measures addressing tick-borne disease prevention and research. The bill is held at the desk pending further legislative action.

Sources: www.congress.gov

Youth Poisoning Protection Act

Senate Bill 289 focuses on policies around youth poisoning prevention. The measure is held at the desk for subsequent consideration.

Sources: www.congress.gov

Diabetes Prevention Program Reauthorization Act of 2026

Bill 10086 proposes to reauthorize the national diabetes prevention program. The bill was referred to the House Committee on Energy and Commerce for review.

Sources: www.congress.gov

Cancer Care Planning and Communications Act

Bill 10087 aims to improve cancer care planning and communication efforts. The proposal was sent to both the Committee on Energy and Commerce and the Committee on Ways and Means for jurisdictional consideration.

Sources: www.congress.gov

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026

Bill 10094 targets pricing for taxpayer-funded prescription drugs, seeking legislative oversight and cost controls. It was referred to the House Committee on Energy and Commerce.

Sources: www.congress.gov

Cancer Research Trust Fund Act

Bill 10093 proposes the creation of a dedicated trust fund for cancer research. The legislation was referred to the House Committee on Energy and Commerce.

Sources: www.congress.gov
ad-card
From operational data to AI readiness. Learn how Intrepid Data Solutions helps SMBs build reliable data foundations for analytics and AI. Visit IDS!

What We're Reading This Week

.